Since ReTT syndrome patients with MeCP2 mutation were found having abnormal pain sensitivity [3], targeting MeCP2 in local region, which is responsible for pain sensation but not other physiological functions will take more attention in future study. The gene discussed is MECP2; the disease is atypical Rett syndrome.